Table 2.
R-Ant./Lat. (N = 12) | R-L comm. (N = 22) | L-Ant./Lat. (N = 17) | P value | |
---|---|---|---|---|
Target amplitude, mV | 0.56 (0.33–0.99)a, b | 0.76 (0.50–1.16)a | 0.41 (0.35–0.67)b | 0.044* |
Target duration, ms | 138.9 ± 14.5 | 139.1 ± 42.6 | 124.9 ± 35.4 | 0.416 |
Earliest activation, ms | 25.8 ± 6.0 | 27.4 ± 7.4 | 29.5 ± 8.3 | 0.469 |
Lead I morphology, n (%) | ||||
R/RR'/RSR' | 11 (91.7)a | 9 (40.9)b | 2 (11.8)b | <0.05* |
Rs (R/S ≥ 1) | 0 | 6 (27.3) | 3 (17.6) | >0.05 |
rS (R/S <1) | 0 | 4 (18.2) | 3 (17.6) | >0.05 |
QS, QRS | 1 (8.3)a | 3 (13.6)a | 9 (52.9)b | <0.05* |
Precordial transition, n (%) | ||||
V1 | 1 (8.3)a | 7 (31.8)a, b | 9 (52.9)b | <0.05* |
V1-2 | 1 (8.3) | 3 (13.6) | 1 (5.9) | >0.05 |
V2 | 1 (8.3) | 2 (9.1) | 0 | >0.05 |
V2-3 | 4 (33.3) | 5 (22.7) | 7 (41.2) | >0.05 |
≥V3 | 5 (41.7) a | 5 (22.7) a, b | 0b | <0.05* |
Precordial rebound notch, n (%) | ||||
None | 0a | 16 (72.7)b | 10 (58.8)b | <0.05* |
V1-2 | 1 (8.3) | 0 | 0 | >0.05 |
V2-3 | 0 | 2 (9.1) | 6 (35.3) | >0.05 |
V3-4 | 9 (75) a | 2 (9.1) b | 1 (5.9) b | <0.05* |
V4-5 | 2 (16.7) | 2 (9.1) | 0 | >0.05 |
Values are presented as the mean ± SD, median (Q1–Q3), or n (%). ASV, aortic sinus of Valsalva; R-Ant./Lat., right-lateral/anterior ASV; R-L Comm., left-right commissure; L-Ant./Lat., left-lateral/anterior ASV. a or bDifferent letters indicate intergroup significance; e.g., for the “target amplitude,” significance is shown between R-L Comm. and L-Ant./Lat.
The Bold values and the symbol
highlight the P value < 0.05.